Investor · 2 deals
Every published round VU Venture Partners took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| JumpStart Fertility | Unnamed stage | 2025 | $4m | Participant | Forbes Australia | |
| Nutromics | Unnamed stage | 9 Sep 2022 | $20.5m | Participant | Startup Daily (3 Sep 2025), SmartCompany, Startup Daily (9 Sep 2022), @AuManufacturing |
Companies VU Venture Partners has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| JumpStart Fertility | 2025 | 1 | 0 | |
| Nutromics | diagnostics startup | 9 Sep 2022 | 1 | 0 |
Fund closes reported for VU Venture Partners, as distinct from the investments it has made.
Companies VU Venture Partners has backed that another company then bought. An exit for the holding, not a deal VU Venture Partners did.
Stories naming VU Venture Partners. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne wearable diagnostics startup Nutromics raised US$14 million (A$20.5 million), led by Dexcom's venture arm with VU Venture Partners and Artesian, to fund clinical studies and expansion.